Our Leadership Team
Frances O’Callaghan – Board Chair
Frances is the Accountable Officer for the North Central London Clinical Commissioning Group. She has worked in the NHS for over 20 years leading clinical services and in strategy roles, most recently as Director of Strategic Implementation and Partnerships at Homerton University Hospital NHS Foundation Trust. She has been responsible for estates, communications and other corporate services at board level, in addition to three years as a director within the corporate finance team at PricewaterhouseCoopers.
Professor Geoff Bellingan – Senior Responsible Officer
Geoff is the Medical Director for Surgery and Cancer at UCLH. He trained as a chest physician and then in intensive care in which he has been a consultant at UCLH since 1997. He was appointed as a professor in intensive care medicine at UCL in 2015.
Geoff has long held interest in cancer care across our area of London which led to the original UCLH Cancer Collaborative application and the award of the national Cancer Vanguard in partnership with Greater Manchester Cancer Vanguard Innovation and Royal Marsden Partners.
Geoff is also the senior responsible officer for the development the University College Hospital Grafton Way Building which incorporates one of the UK’s first two NHS Proton Beam Therapy units, and a short stay surgical centre.
Holly Norman – Interim Programme Director
Holly Norman became Interim Programme Director in October 2021. She had been a Programme Lead in the Cancer Alliance since 2017 and covered strategy and programme management, with a focus on cancer diagnostics and the workforce for cancer services across north London. Previously, she was part of the national Strategy Group at NHS England where she ran the NHS Healthy New Towns programme, and also worked on the development of the NHS Five Year Forward View. Holly’s NHS career began at Whittington Health NHS Trust, and she has also worked in local government. She studied English Literature at Durham and Oxford Universities, and has an MSc in Health Policy from Imperial College London.
Professor Derralynn Hughes – Clinical Co-Director
Professor Derralynn Hughes is Professor of Experimental Haematology at UCL and Clinical Director of Research and Innovation at the Royal Free London NHS Foundation Trust. She has clinical responsibilities in the area of blood and lysosomal storage disorders (LSD) and has a particular interest in understanding why some of these disorders predispose people to haematological and other malignancies. She is principal investigator of a number of clinical trials of new therapies. Derralynn has been involved in the leadership of cancer services for many years, most recently as clinical director for haematology, oncology and palliative care and lead cancer physician at the Royal Free Hospital.
Dr Clare Stephens – Clinical Co-Director
Clare Stephens is a North London GP and has worked in clinical commissioning since 2002. She is clinical senior responsible officer for cancer for the North Central London integrated care system. Clare is a member of the North Central London Clinical Commissioning Group’s (CCG) governing body. She has held several portfolios for appraisal, acute commissioning, cancer, public health, women and child health, and a pan-London specialist commissioning role. Past senior roles include a Clinical Directorship for Barnet Primary Care Trust, Barnet CCG Governing Body and a pan London NHSE role in cancer.
Afsana is an Islington-based GP and has been the Cancer GP for the Alliance since 2015. She is leading a collaborative project with the digital provider for north central London (Cerner) to create a population health management registry for patients living with cancer in the community. Previous projects include innovating and implementing the EMIS Web electronic safety netting toolkit, which became a national product. She has also produced educational material to support GP cancer care improvement in earlier diagnosis and cancer care reviews. As a portfolio GP, Afsana has a role in the North Central London Clinical Commissioning Group as the evidence-based intervention lead. She is also a GP Appraiser for NHS England. She is a former GP governing body member for Islington CCG and has authored and reviewed online education modules for the Royal College of General Practitioners. She studied medicine at Imperial College London.
Sharon’s programmes of work include: primary care, personalised care for cancer, screening and user involvement. Sharon has held senior clinical, strategic and professional lead roles within palliative care and cancer services in London since 2002. An Occupational Therapist by background, Sharon’s clinical area of expertise is palliative rehabilitation.
Donna is Head of the Centre for Cancer Outcomes. She has worked in the field of surgery for over eight years following her medical degree at King’s College London, and has first-hand experience of delivering acute services in the NHS. Prior to joining the team, she worked for one of the leading private clinics in London, with a strong focus on innovative approaches to improve the quality and efficiency of services. Donna is passionate about implementing value-based healthcare and advancing medical leadership. She led the multidisciplinary diagnostic centres pilot in north central and east London (predecessor of Rapid Diagnostic Centres).
Marc Delon has worked in acute tertiary hospital trusts in London since 2006. He has a wealth of operational management experience from his roles at Kings College Hospital Foundation Trust, Guys and St Thomas’ Hospital Foundation Trust and University College London Hospital Foundation Trust. Marc has had experience in hospital wide roles responsible for elective access both in cancer and non-cancer. He is a former manager of the University College Hospital and has been Interim Divisional Manager for Women’s Health at UCLH. He is passionate about equity of access and addressing health inequalities. He has a particular interest in clinical research, in particular accelerating the transition of discoveries in basic science to NHS services to benefit patient care.